Interleukin 2 for patients with renal cancer
- PMID: 17728709
- PMCID: PMC2147080
- DOI: 10.1038/ncponc0926
Interleukin 2 for patients with renal cancer
Conflict of interest statement
Competing interests: The author declared no competing interests.
Comment on
-
What are the indications for sorafenib treatment in patients with renal cell carcinoma?Nat Clin Pract Oncol. 2007 Aug;4(8):456-7. doi: 10.1038/ncponc0880. Epub 2007 Jun 19. Nat Clin Pract Oncol. 2007. PMID: 17579598 No abstract available.
-
Sunitinib--a new standard of care for metastatic renal cell carcinoma.Nat Clin Pract Oncol. 2007 Aug;4(8):458-9. doi: 10.1038/ncponc0882. Epub 2007 Jun 26. Nat Clin Pract Oncol. 2007. PMID: 17593923 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical